Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-KitMalak Sabbah, Fabrice Journé|Molecular Cancer Research|2021Cited by 8